Trelle S, et al. Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis. BMJ 2011; 342:c7086
Non-steroidal anti-inflammatory drugs (NSAIDs) appear to be associated with increased cardiovascular risks.
Category: Clinical domain
Permanent link to this article: https://evidencebasedmedicine.com.au/?p=1173
Permanent link to this article: https://evidencebasedmedicine.com.au/?p=1046
Mar 02 2011
DHA on maternal depression and neurodevelopment
Makrides M, et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA. 2010; 304(15): 1675-1683
DHA supplements in the later half of pregnancy are not associated with improvements in maternal depression or infant neurodevelopment.
Permanent link to this article: https://evidencebasedmedicine.com.au/?p=989
Permanent link to this article: https://evidencebasedmedicine.com.au/?p=993
Permanent link to this article: https://evidencebasedmedicine.com.au/?p=182
Permanent link to this article: https://evidencebasedmedicine.com.au/?p=191
Permanent link to this article: https://evidencebasedmedicine.com.au/?p=542
Permanent link to this article: https://evidencebasedmedicine.com.au/?p=1264
Permanent link to this article: https://evidencebasedmedicine.com.au/?p=723
Feb 14 2011
Statins, coronary heart disease and abnormal LFTs
Athyros VG, et al. Safety and efficacy of long-term statin treatment for cardiovascular events in patients with CHD and abnormal LFTs in GREACE Study: a post-hoc analysis. Lancet 2010; 376: 1916–22
Statin are effective and safe in patients with established coronary heart disease but with mild-to-moderate abnormal liver function tests.
Permanent link to this article: https://evidencebasedmedicine.com.au/?p=686
Recent Comments